Loading…

Browse All Grants

99,167 grants found

Filters
Reset

Showing 1,4811,500 of 99,167 grants

Active NON-SBIR/STTR RPGS
Defining Actionable Opportunities in Malignant Phyllodes via Genomic Profiling
FOOD AND DRUG ADMINISTRATION Duke University United States 2024 – 2027

ABSTRACT Malignant phyllodes tumors (MPT) are extremely rare primary breast cancers, which are globally understudied due the infrequency of the diagnosis and to the unfamiliarity w...

$14.89M
USD
Active NON-SBIR/STTR RPGS
Integrative proteogenomics for elucidation of tumor-specific cell surface proteomes in ultra-rare cancers
FOOD AND DRUG ADMINISTRATION Sloan-Kettering Inst Can Research United States 2024 – 2027

Project Summary Despite advances in treatment, sarcomas like rhabdoid tumors and desmoplastic small round cell tumors (DSRCT) remain challenging, with frequent therapy resistance a...

$14.96M
USD
Active NON-SBIR/STTR RPGS
Inflammation and EGFR crosstalk in HNSCC Therapy
NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEAR... University of Iowa United States 2024 – 2029

Project Summary Given the importance of oncogenic epidermal growth factor receptor (EGFR) signaling for tumor cell proliferation in head and neck squamous cell carcinoma (HNSCC), w...

$3.54M
USD
Completed NON-SBIR/STTR RPGS
Insulin and Immune Mechanisms in Obesity-Induced Renal Disease
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND K... University of Mississippi Med Ctr United States 2024 – 2025

Prepubertal childhood obesity (PPO) has emerged as an epidemic and major health problem in the United States. Recent studies suggest that PPO is associated with increased risk of r...

$2M
USD
Active NON-SBIR/STTR RPGS
Oocyte mitochondrial activity regulates embryo telomere reprogramming
EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD... Oregon Health & Science University United States 2024 – 2028

PROJECT SUMMARY Telomeres, the repetitive DNA at the ends of chromosomes, shorten during every cell division except in very exceptional circumstances; in particular, rapid telomere...

$5.13M
USD
Active NON-SBIR/STTR RPGS
Pathobiology of autoimmune-mediated diffuse podocytopathy
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND K... Brigham and Women'S Hospital United States 2024 – 2029

Project Summary/Abstract Minimal change disease and primary focal and segmental glomerulosclerosis are morphologic expressions of a diffuse podocytopathy of to date unknown cause,...

$7.96M
USD
Active NON-SBIR/STTR RPGS
Glycinergic inhibition in the ventral brainstem
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND K... Tulane University of Louisiana United States 2024 – 2028

Project Summary The autonomic nervous system (ANS) regulates multiple aspects of energy homeostasis including food intake, energy expenditure, lipid metabolism, and glucose homeost...

$4.2M
USD
Active NON-SBIR/STTR RPGS
Investigating the role of gut-derived extracellular vesicles in PTSD following TBI
NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND S... Henry Ford Health + Michigan State Unive... United States 2024 – 2029

Abstract Veterans and the general public with traumatic brain injury (TBI) have a high risk of developing posttraumatic stress disorder (PTSD) and other psychiatric disorders, such...

$4.85M
USD
Active NON-SBIR/STTR RPGS
Bacteriophage strategies to lyse bacterial cells
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES Texas A&M University United States 2024 – 2029

Project Summary Bacteriophage, or phage, infect and kill bacterial cells. At a programmed time, phage use a tailored suite of proteins to release newly built virions by lysing the...

$3.65M
USD
Active NON-SBIR/STTR RPGS
3/5 Clinical Outcome Prediction of Psychosis from Electronic Health Records (COPPER)
NATIONAL INSTITUTE OF MENTAL HEALTH New York University School of Medicine United States 2024 – 2029

PROJECT SUMMARY Clinical predictors are now firmly incorporated into routine standard-of-care in many fields of medicine, in contrast with Psychiatry where quantitative predictors...

$2.54M
USD
Active NON-SBIR/STTR RPGS
A clinical decision support tool to understand the survival benefit of kidney transplantation in candidates with a history of cancer
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND K... Hennepin Healthcare Research Institute United States 2024 – 2029

PROJECT SUMMARY / ABSTRACT: Survival with end-stage kidney disease (ESKD) has improved in the last decade alongside the trend of an aging population with greater risks, including c...

$3.49M
USD
Active NON-SBIR/STTR RPGS
5/5 Clinical Outcome Prediction of Psychosis from Electronic Health Records (COPPER)
NATIONAL INSTITUTE OF MENTAL HEALTH University of Chicago United States 2024 – 2029

PROJECT SUMMARY Clinical predictors are now firmly incorporated into routine standard-of-care in many fields of medicine, in contrast with Psychiatry where quantitative predictors...

$2.87M
USD
Active NON-SBIR/STTR RPGS
Skeletal Myosin-Binding Protein C: Defining Function Across Scales Using a Zebrafish Model System.
NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETA... University of Vermont & St Agric College United States 2024 – 2026

Myosin-binding protein C (MyBP-C), a thick filament associated protein of vertebrate striated muscle, is a key modulator of muscle contractility. Multiple distinct skeletal muscle...

$2.02M
USD
Active NON-SBIR/STTR RPGS
Methods to build and annotate tissue atlases using spatial genomic data
NATIONAL HUMAN GENOME RESEARCH INSTITUTE J. David Gladstone Institutes United States 2024 – 2028

Project Summary/Abstract Single-cell spatial technologies hold the promise of understanding spatially-resolved cell state and discovering how cells interact locally to create compl...

$8.3M
USD
Active NON-SBIR/STTR RPGS
Impact of dietary lipids on pancreas cancer initiation and progression
NATIONAL CANCER INSTITUTE University of California Los Angeles United States 2024 – 2026

PROJECT SUMMARY Despite advances in cancer treatment, the five-year survival rate for pancreatic ductal adenocarcinoma (PDA) is 12%. Obesity has been linked to PDA risk epidemiolog...

$2.58M
USD
Active NON-SBIR/STTR RPGS
Fimepinostat, Combination HDAC and Pi3-kinase Inhibitor Tumor-Directed Therapy for Cushing Disease (IND 168501 - 07/31/2023)
FOOD AND DRUG ADMINISTRATION University of California Los Angeles United States 2024 – 2028

Abstract Cushing Disease (CD) a life-threatening “orphan disease” with an annual US incidence of ~8 cases per million. It is caused by an adrenocorticotropic hormone (ACTH)-secreti...

$4.25M
USD
Active NON-SBIR/STTR RPGS
Whole Protein Arrays to Detect Antimicrobial Antibodies Associated with Triggering and Progression of Islet Autoimmunity in TEDDY
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND K... Arizona State University-Tempe Campus United States 2024 – 2027

Abstract Type 1 diabetes (T1D) is a multifactorial disease caused by a complex interplay of genetic and environmental factors. The genes that mediate disease susceptibility have la...

$14.49M
USD
Active NON-SBIR/STTR RPGS
Functional roles of DDX41 in the homeostasis of G quadruplexes in erythropoiesis
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND K... Northwestern University At Chicago United States 2024 – 2029

Project Summary Increased evidence started to show that many germline mutations predispose individuals to myeloid neoplasms, including myelodysplastic syndromes (MDS). One of these...

$4.75M
USD
Active NON-SBIR/STTR RPGS
4/5 Biomarkers to Enhance Early Schizophrenia Treatment (BEEST)
NATIONAL INSTITUTE OF MENTAL HEALTH University of Alabama At Birmingham United States 2024 – 2029

PROJECT SUMMARY The onset of a first episode of psychosis (FEP) in late adolescence or early adulthood often leads to lifelong disability. Timing and precision of treatment are of...

$3.66M
USD
Active NON-SBIR/STTR RPGS
Determining the mechanisms of extracellular vesicle release, function, and clearance
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES Texas A&M Agrilife Research United States 2024 – 2029

Project Summary/Abstract Cells release extracellular vesicles (EVs) that carry signals to alter cell fate or metabolism, promote invasive behavior, or modulate the immune response....

$3.67M
USD